Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Paul M. Ridker, M.D.

Co-Author

This page shows the publications co-authored by Paul Ridker and Julie Buring.
Connection Strength

12.311
  1. Use of aspirin as primary prevention of cardiovascular events. JAMA. 2006 Jul 26; 296(4):391; author reply 391-2.
    View in: PubMed
    Score: 0.361
  2. Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. JAMA. 2005 Jul 20; 294(3):326-33.
    View in: PubMed
    Score: 0.336
  3. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med. 2005 Mar 31; 352(13):1293-304.
    View in: PubMed
    Score: 0.328
  4. Association of Migraine With Aura and Other Risk Factors With Incident Cardiovascular Disease in Women. JAMA. 2020 06 09; 323(22):2281-2289.
    View in: PubMed
    Score: 0.236
  5. Homocysteine, B Vitamins, MTHFR Genotype, and Incident Age-related Macular Degeneration. Ophthalmol Retina. 2018 May; 2(5):508-510.
    View in: PubMed
    Score: 0.204
  6. Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening. JAMA. 1997 Apr 23-30; 277(16):1305-7.
    View in: PubMed
    Score: 0.189
  7. Anti-platelet effects of 100 mg alternate day oral aspirin: a randomized, double-blind, placebo-controlled trial of regular and enteric coated formulations in men and women. J Cardiovasc Risk. 1996 Apr; 3(2):209-12.
    View in: PubMed
    Score: 0.176
  8. Prospective study of plasma homocysteine level and risk of age-related macular degeneration in women. Ophthalmic Epidemiol. 2015 Apr; 22(2):85-93.
    View in: PubMed
    Score: 0.165
  9. Cardiovascular risks associated with incident and prevalent periodontal disease. J Clin Periodontol. 2015 Jan; 42(1):21-8.
    View in: PubMed
    Score: 0.162
  10. Discordance of low-density lipoprotein (LDL) cholesterol with alternative LDL-related measures and future coronary events. Circulation. 2014 Feb 04; 129(5):553-61.
    View in: PubMed
    Score: 0.151
  11. Comparison of delay times to hospital presentation for physicians and nonphysicians with acute myocardial infarction. Am J Cardiol. 1992 Jul 01; 70(1):10-3.
    View in: PubMed
    Score: 0.136
  12. Tomato-based food products are related to clinically modest improvements in selected coronary biomarkers in women. J Nutr. 2012 Feb; 142(2):326-33.
    View in: PubMed
    Score: 0.132
  13. Geographic variation in cardiovascular inflammation among healthy women in the Women's Health Study. PLoS One. 2011; 6(11):e27468.
    View in: PubMed
    Score: 0.130
  14. Lipoprotein(a) and risk of type 2 diabetes. Clin Chem. 2010 Aug; 56(8):1252-60.
    View in: PubMed
    Score: 0.118
  15. Lipoprotein particle size and concentration by nuclear magnetic resonance and incident type 2 diabetes in women. Diabetes. 2010 May; 59(5):1153-60.
    View in: PubMed
    Score: 0.116
  16. Association between a literature-based genetic risk score and cardiovascular events in women. JAMA. 2010 Feb 17; 303(7):631-7.
    View in: PubMed
    Score: 0.115
  17. Kidney function and risk of cardiovascular disease and mortality in women: a prospective cohort study. BMJ. 2009 Jun 29; 338:b2392.
    View in: PubMed
    Score: 0.110
  18. Prediction of incident hypertension risk in women with currently normal blood pressure. Am J Med. 2009 May; 122(5):464-71.
    View in: PubMed
    Score: 0.109
  19. Comparison of LDL cholesterol concentrations by Friedewald calculation and direct measurement in relation to cardiovascular events in 27,331 women. Clin Chem. 2009 May; 55(5):888-94.
    View in: PubMed
    Score: 0.109
  20. Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women. Circulation. 2009 Feb 24; 119(7):931-9.
    View in: PubMed
    Score: 0.108
  21. Lipid biomarkers, hormone therapy and the risk of venous thromboembolism in women. J Thromb Haemost. 2009 Apr; 7(4):588-96.
    View in: PubMed
    Score: 0.107
  22. Cardiovascular disease risk prediction with and without knowledge of genetic variation at chromosome 9p21.3. Ann Intern Med. 2009 Jan 20; 150(2):65-72.
    View in: PubMed
    Score: 0.107
  23. A randomized trial of low-dose aspirin in the prevention of clinical type 2 diabetes in women. Diabetes Care. 2009 Jan; 32(1):3-8.
    View in: PubMed
    Score: 0.105
  24. Genetic loci associated with plasma concentration of low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides, apolipoprotein A1, and Apolipoprotein B among 6382 white women in genome-wide analysis with replication. Circ Cardiovasc Genet. 2008 Oct; 1(1):21-30.
    View in: PubMed
    Score: 0.105
  25. Fasting compared with nonfasting lipids and apolipoproteins for predicting incident cardiovascular events. Circulation. 2008 Sep 02; 118(10):993-1001.
    View in: PubMed
    Score: 0.104
  26. Polymorphism in the apolipoprotein(a) gene, plasma lipoprotein(a), cardiovascular disease, and low-dose aspirin therapy. Atherosclerosis. 2009 Apr; 203(2):371-6.
    View in: PubMed
    Score: 0.104
  27. Lipoprotein(a), hormone replacement therapy, and risk of future cardiovascular events. J Am Coll Cardiol. 2008 Jul 08; 52(2):124-31.
    View in: PubMed
    Score: 0.103
  28. Loci related to metabolic-syndrome pathways including LEPR,HNF1A, IL6R, and GCKR associate with plasma C-reactive protein: the Women's Genome Health Study. Am J Hum Genet. 2008 May; 82(5):1185-92.
    View in: PubMed
    Score: 0.102
  29. Interleukin-18 and the risk of future cardiovascular disease among initially healthy women. Atherosclerosis. 2009 Jan; 202(1):282-8.
    View in: PubMed
    Score: 0.102
  30. Rationale, design, and methodology of the Women's Genome Health Study: a genome-wide association study of more than 25,000 initially healthy american women. Clin Chem. 2008 Feb; 54(2):249-55.
    View in: PubMed
    Score: 0.099
  31. Plasma concentration of heat shock protein 27 and risk of cardiovascular disease: a prospective, nested case-control study. Clin Chem. 2008 Jan; 54(1):139-46.
    View in: PubMed
    Score: 0.099
  32. Migraine and biomarkers of cardiovascular disease in women. Cephalalgia. 2008 Jan; 28(1):49-56.
    View in: PubMed
    Score: 0.099
  33. Intercellular adhesion molecule 1 (ICAM1) Lys56Met and Gly241Arg gene variants, plasma-soluble ICAM1 concentrations, and risk of incident cardiovascular events in 23,014 initially healthy white women. Stroke. 2007 Dec; 38(12):3152-7.
    View in: PubMed
    Score: 0.098
  34. Effect of low-dose aspirin on the occurrence of venous thromboembolism: a randomized trial. Ann Intern Med. 2007 Oct 16; 147(8):525-33.
    View in: PubMed
    Score: 0.098
  35. Effects of random allocation to vitamin E supplementation on the occurrence of venous thromboembolism: report from the Women's Health Study. Circulation. 2007 Sep 25; 116(13):1497-503.
    View in: PubMed
    Score: 0.097
  36. Hemoglobin A1c predicts diabetes but not cardiovascular disease in nondiabetic women. Am J Med. 2007 Aug; 120(8):720-7.
    View in: PubMed
    Score: 0.097
  37. Differential effect of soluble intercellular adhesion molecule-1 on the progression of atherosclerosis as compared to arterial thrombosis: a prospective analysis of the Women's Health Study. Atherosclerosis. 2008 Mar; 197(1):297-302.
    View in: PubMed
    Score: 0.097
  38. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA. 2007 Jul 18; 298(3):309-16.
    View in: PubMed
    Score: 0.096
  39. C-reactive protein and risk of breast cancer. J Natl Cancer Inst. 2007 Jun 06; 99(11):890-4.
    View in: PubMed
    Score: 0.096
  40. Relation between soluble intercellular adhesion molecule-1, homocysteine, and fibrinogen levels and race/ethnicity in women without cardiovascular disease. Am J Cardiol. 2007 May 01; 99(9):1246-51.
    View in: PubMed
    Score: 0.094
  41. Homocysteine, 5,10-methylenetetrahydrofolate reductase 677C>T polymorphism, nutrient intake, and incident cardiovascular disease in 24,968 initially healthy women. Clin Chem. 2007 May; 53(5):845-51.
    View in: PubMed
    Score: 0.094
  42. High-sensitivity C-reactive protein, other markers of inflammation, and the incidence of macular degeneration in women. Arch Ophthalmol. 2007 Mar; 125(3):300-5.
    View in: PubMed
    Score: 0.094
  43. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA. 2007 Feb 14; 297(6):611-9.
    View in: PubMed
    Score: 0.094
  44. Impact of traditional and novel risk factors on the relationship between socioeconomic status and incident cardiovascular events. Circulation. 2006 Dec 12; 114(24):2619-26.
    View in: PubMed
    Score: 0.092
  45. The relative strength of C-reactive protein and lipid levels as determinants of ischemic stroke compared with coronary heart disease in women. J Am Coll Cardiol. 2006 Dec 05; 48(11):2235-42.
    View in: PubMed
    Score: 0.092
  46. Lipoprotein(a), measured with an assay independent of apolipoprotein(a) isoform size, and risk of future cardiovascular events among initially healthy women. JAMA. 2006 Sep 20; 296(11):1363-70.
    View in: PubMed
    Score: 0.091
  47. Additive value of immunoassay-measured fibrinogen and high-sensitivity C-reactive protein levels for predicting incident cardiovascular events. Circulation. 2006 Aug 01; 114(5):381-7.
    View in: PubMed
    Score: 0.090
  48. The effect of including C-reactive protein in cardiovascular risk prediction models for women. Ann Intern Med. 2006 Jul 04; 145(1):21-9.
    View in: PubMed
    Score: 0.090
  49. Association of physical activity and body mass index with novel and traditional cardiovascular biomarkers in women. JAMA. 2006 Mar 22; 295(12):1412-9.
    View in: PubMed
    Score: 0.088
  50. Dietary calcium, vitamin D, and the prevalence of metabolic syndrome in middle-aged and older U.S. women. Diabetes Care. 2005 Dec; 28(12):2926-32.
    View in: PubMed
    Score: 0.086
  51. Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial. JAMA. 2005 Jul 06; 294(1):47-55.
    View in: PubMed
    Score: 0.084
  52. Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial. JAMA. 2005 Jul 06; 294(1):56-65.
    View in: PubMed
    Score: 0.084
  53. Aspirin and cardiovascular disease prevention in women: new findings from the Women's Health Study. Womens Health (Lond). 2005 Jul; 1(1):9-10.
    View in: PubMed
    Score: 0.084
  54. C-reactive protein levels are not associated with increased risk for colorectal cancer in women. Ann Intern Med. 2005 Mar 15; 142(6):425-32.
    View in: PubMed
    Score: 0.082
  55. C-reactive protein levels among women of various ethnic groups living in the United States (from the Women's Health Study). Am J Cardiol. 2004 May 15; 93(10):1238-42.
    View in: PubMed
    Score: 0.077
  56. C-reactive protein and the risk of developing hypertension. JAMA. 2003 Dec 10; 290(22):2945-51.
    View in: PubMed
    Score: 0.075
  57. Blood pressure, C-reactive protein, and risk of future cardiovascular events. Circulation. 2003 Dec 16; 108(24):2993-9.
    View in: PubMed
    Score: 0.075
  58. Relationship of total and abdominal adiposity with CRP and IL-6 in women. Ann Epidemiol. 2003 Nov; 13(10):674-82.
    View in: PubMed
    Score: 0.075
  59. Sex hormone levels and risk of cardiovascular events in postmenopausal women. Circulation. 2003 Oct 07; 108(14):1688-93.
    View in: PubMed
    Score: 0.074
  60. Insulin, proinsulin, proinsulin:insulin ratio, and the risk of developing type 2 diabetes mellitus in women. Am J Med. 2003 Apr 15; 114(6):438-44.
    View in: PubMed
    Score: 0.072
  61. C-reactive protein is independently associated with fasting insulin in nondiabetic women. Arterioscler Thromb Vasc Biol. 2003 Apr 01; 23(4):650-5.
    View in: PubMed
    Score: 0.071
  62. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation. 2003 Jan 28; 107(3):391-7.
    View in: PubMed
    Score: 0.071
  63. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med. 2002 Nov 14; 347(20):1557-65.
    View in: PubMed
    Score: 0.070
  64. Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women. Arterioscler Thromb Vasc Biol. 2002 Oct 01; 22(10):1668-73.
    View in: PubMed
    Score: 0.069
  65. Concentration in plasma of macrophage inhibitory cytokine-1 and risk of cardiovascular events in women: a nested case-control study. Lancet. 2002 Jun 22; 359(9324):2159-63.
    View in: PubMed
    Score: 0.068
  66. Relation between markers of systemic vascular inflammation and smoking in women. Am J Cardiol. 2002 May 01; 89(9):1117-9.
    View in: PubMed
    Score: 0.067
  67. Is C-reactive protein specific for vascular disease in women? Ann Intern Med. 2002 Apr 02; 136(7):529-33.
    View in: PubMed
    Score: 0.067
  68. Relation between a diet with a high glycemic load and plasma concentrations of high-sensitivity C-reactive protein in middle-aged women. Am J Clin Nutr. 2002 Mar; 75(3):492-8.
    View in: PubMed
    Score: 0.066
  69. Soluble CD40L and cardiovascular risk in women. Circulation. 2001 Nov 06; 104(19):2266-8.
    View in: PubMed
    Score: 0.065
  70. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA. 2001 Jul 18; 286(3):327-34.
    View in: PubMed
    Score: 0.064
  71. Publisher Correction: Discovery of rare variants associated with blood pressure regulation through meta-analysis of 1.3 million individuals. Nat Genet. 2021 Mar 16.
    View in: PubMed
    Score: 0.062
  72. Association of Genetic Variants With Migraine Subclassified by Clinical Symptoms in Adult Females. Front Neurol. 2020; 11:617472.
    View in: PubMed
    Score: 0.062
  73. Soluble P-selectin and the risk of future cardiovascular events. Circulation. 2001 Jan 30; 103(4):491-5.
    View in: PubMed
    Score: 0.062
  74. Discovery of rare variants associated with blood pressure regulation through meta-analysis of 1.3 million individuals. Nat Genet. 2020 12; 52(12):1314-1332.
    View in: PubMed
    Score: 0.061
  75. Triglyceride-Rich Lipoprotein Cholesterol, Small Dense LDL Cholesterol, and Incident Cardiovascular Disease. J Am Coll Cardiol. 2020 05 05; 75(17):2122-2135.
    View in: PubMed
    Score: 0.059
  76. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000 Mar 23; 342(12):836-43.
    View in: PubMed
    Score: 0.058
  77. Genetic variation at the coronary artery disease risk locus GUCY1A3 modifies cardiovascular disease prevention effects of aspirin. Eur Heart J. 2019 11 01; 40(41):3385-3392.
    View in: PubMed
    Score: 0.057
  78. Genome-wide association and epidemiological analyses reveal common genetic origins between uterine leiomyomata and endometriosis. Nat Commun. 2019 10 24; 10(1):4857.
    View in: PubMed
    Score: 0.056
  79. Baseline IgG antibody titers to Chlamydia pneumoniae, Helicobacter pylori, herpes simplex virus, and cytomegalovirus and the risk for cardiovascular disease in women. Ann Intern Med. 1999 Oct 19; 131(8):573-7.
    View in: PubMed
    Score: 0.056
  80. Hormone replacement therapy and increased plasma concentration of C-reactive protein. Circulation. 1999 Aug 17; 100(7):713-6.
    View in: PubMed
    Score: 0.056
  81. Quality of dietary fat and genetic risk of type 2 diabetes: individual participant data meta-analysis. BMJ. 2019 07 25; 366:l4292.
    View in: PubMed
    Score: 0.055
  82. Plasma Placental Growth Factor Concentrations Are Elevated Well in Advance of Type 2 Diabetes Mellitus Onset: Prospective Data From the WHS. J Am Heart Assoc. 2019 08 06; 8(15):e012790.
    View in: PubMed
    Score: 0.055
  83. COMT and Alpha-Tocopherol Effects in Cancer Prevention: Gene-Supplement Interactions in Two Randomized Clinical Trials. J Natl Cancer Inst. 2019 07 01; 111(7):684-694.
    View in: PubMed
    Score: 0.055
  84. Homocysteine and risk of cardiovascular disease among postmenopausal women. JAMA. 1999 May 19; 281(19):1817-21.
    View in: PubMed
    Score: 0.055
  85. Lipid levels and the risk of hemorrhagic stroke among women. Neurology. 2019 05 07; 92(19):e2286-e2294.
    View in: PubMed
    Score: 0.054
  86. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation. 1998 Aug 25; 98(8):731-3.
    View in: PubMed
    Score: 0.052
  87. Family History of MI, Smoking, and Risk of Periodontal Disease. J Dent Res. 2018 09; 97(10):1106-1113.
    View in: PubMed
    Score: 0.051
  88. Factor V Leiden mutation as a risk factor for recurrent pregnancy loss. Ann Intern Med. 1998 Jun 15; 128(12 Pt 1):1000-3.
    View in: PubMed
    Score: 0.051
  89. Physical Activity and Incident Cardiovascular Disease in Women: Is the Relation Modified by Level of Global Cardiovascular Risk? J Am Heart Assoc. 2018 06 12; 7(12).
    View in: PubMed
    Score: 0.051
  90. Markers of Inflammation and Incident Breast Cancer Risk in the Women's Health Study. Am J Epidemiol. 2018 04 01; 187(4):705-716.
    View in: PubMed
    Score: 0.051
  91. Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes. Nat Genet. 2018 04; 50(4):524-537.
    View in: PubMed
    Score: 0.050
  92. Association between Vitamin D Genetic Risk Score and Cancer Risk in a Large Cohort of U.S. Women. Nutrients. 2018 Jan 09; 10(1).
    View in: PubMed
    Score: 0.050
  93. Genome-wide association meta-analysis of fish and EPA+DHA consumption in 17 US and European cohorts. PLoS One. 2017; 12(12):e0186456.
    View in: PubMed
    Score: 0.050
  94. Analysis of potential protein-modifying variants in 9000 endometriosis patients and 150000 controls of European ancestry. Sci Rep. 2017 09 12; 7(1):11380.
    View in: PubMed
    Score: 0.049
  95. Meta-analysis identifies five novel loci associated with endometriosis highlighting key genes involved in hormone metabolism. Nat Commun. 2017 05 24; 8:15539.
    View in: PubMed
    Score: 0.048
  96. Genomic analyses identify hundreds of variants associated with age at menarche and support a role for puberty timing in cancer risk. Nat Genet. 2017 Jun; 49(6):834-841.
    View in: PubMed
    Score: 0.047
  97. Discordance between Circulating Atherogenic Cholesterol Mass and Lipoprotein Particle Concentration in Relation to Future Coronary Events in Women. Clin Chem. 2017 04; 63(4):870-879.
    View in: PubMed
    Score: 0.047
  98. Association of N-Linked Glycoprotein Acetyls and Colorectal Cancer Incidence and Mortality. PLoS One. 2016; 11(11):e0165615.
    View in: PubMed
    Score: 0.046
  99. Genome-wide analysis identifies 12 loci influencing human reproductive behavior. Nat Genet. 2016 12; 48(12):1462-1472.
    View in: PubMed
    Score: 0.046
  100. Corrigendum: Meta-analysis of 375,000 individuals identifies 38 susceptibility loci for migraine. Nat Genet. 2016 09 28; 48(10):1296.
    View in: PubMed
    Score: 0.046
  101. Meta-analysis of 375,000 individuals identifies 38 susceptibility loci for migraine. Nat Genet. 2016 08; 48(8):856-66.
    View in: PubMed
    Score: 0.045
  102. Association Between Markers of Inflammation and Total Stroke by Hypertensive Status Among Women. Am J Hypertens. 2016 09; 29(9):1117-24.
    View in: PubMed
    Score: 0.045
  103. Lipid biomarkers and long-term risk of cancer in the Women's Health Study. Am J Clin Nutr. 2016 06; 103(6):1397-407.
    View in: PubMed
    Score: 0.044
  104. Physical and neurobehavioral determinants of reproductive onset and success. Nat Genet. 2016 06; 48(6):617-623.
    View in: PubMed
    Score: 0.044
  105. Circulating N-Linked Glycoprotein Acetyls and Longitudinal Mortality Risk. Circ Res. 2016 Apr 01; 118(7):1106-15.
    View in: PubMed
    Score: 0.044
  106. Corrigendum: Rare coding variants and X-linked loci associated with age at menarche. Nat Commun. 2015 Dec 17; 6:10257.
    View in: PubMed
    Score: 0.043
  107. Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair. Nat Genet. 2015 Nov; 47(11):1294-1303.
    View in: PubMed
    Score: 0.043
  108. Plasma Inflammatory Markers and the Risk of Developing Hypertension in Men. J Am Heart Assoc. 2015 Sep 21; 4(9):e001802.
    View in: PubMed
    Score: 0.043
  109. A comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery disease. Nat Genet. 2015 Oct; 47(10):1121-1130.
    View in: PubMed
    Score: 0.042
  110. Rare coding variants and X-linked loci associated with age at menarche. Nat Commun. 2015 Aug 04; 6:7756.
    View in: PubMed
    Score: 0.042
  111. Correction: Selectivity in Genetic Association with Sub-classified Migraine in Women. PLoS Genet. 2015 Jun; 11(6):e1005330.
    View in: PubMed
    Score: 0.042
  112. Plasma C-reactive protein and risk of breast cancer in two prospective studies and a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2015 Aug; 24(8):1199-206.
    View in: PubMed
    Score: 0.042
  113. Novel protein glycan side-chain biomarker and risk of incident type 2 diabetes mellitus. Arterioscler Thromb Vasc Biol. 2015 Jun; 35(6):1544-50.
    View in: PubMed
    Score: 0.041
  114. Vitamin D-associated genetic variation and risk of breast cancer in the breast and prostate cancer cohort consortium (BPC3). Cancer Epidemiol Biomarkers Prev. 2015 Mar; 24(3):627-30.
    View in: PubMed
    Score: 0.040
  115. Individualised prediction of alternate-day aspirin treatment effects on the combined risk of cancer, cardiovascular disease and gastrointestinal bleeding in healthy women. Heart. 2015 Mar; 101(5):369-76.
    View in: PubMed
    Score: 0.040
  116. Inactivating mutations in NPC1L1 and protection from coronary heart disease. N Engl J Med. 2014 Nov 27; 371(22):2072-82.
    View in: PubMed
    Score: 0.040
  117. A novel protein glycan biomarker and future cardiovascular disease events. J Am Heart Assoc. 2014 Sep 23; 3(5):e001221.
    View in: PubMed
    Score: 0.040
  118. Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche. Nature. 2014 Oct 02; 514(7520):92-97.
    View in: PubMed
    Score: 0.039
  119. Polymorphisms in catechol-O-methyltransferase modify treatment effects of aspirin on risk of cardiovascular disease. Arterioscler Thromb Vasc Biol. 2014 Sep; 34(9):2160-7.
    View in: PubMed
    Score: 0.039
  120. Selectivity in genetic association with sub-classified migraine in women. PLoS Genet. 2014 May; 10(5):e1004366.
    View in: PubMed
    Score: 0.039
  121. Catechol-O-methyltransferase Associated Risk of Cardiovascular Disease Is Modified by Treatment with Vitamin E. J Altern Complement Med. 2014 May; 20(5):A3.
    View in: PubMed
    Score: 0.039
  122. Common genetic variations in the vitamin D pathway in relation to blood pressure. Am J Hypertens. 2014 Nov; 27(11):1387-95.
    View in: PubMed
    Score: 0.038
  123. DNA mismatch repair gene MSH6 implicated in determining age at natural menopause. Hum Mol Genet. 2014 May 01; 23(9):2490-7.
    View in: PubMed
    Score: 0.038
  124. A prospective study of circulating C-reactive protein, interleukin-6, and tumor necrosis factor a receptor 2 levels and risk of ovarian cancer. Am J Epidemiol. 2013 Oct 15; 178(8):1256-64.
    View in: PubMed
    Score: 0.037
  125. Genome-wide meta-analysis identifies new susceptibility loci for migraine. Nat Genet. 2013 Aug; 45(8):912-917.
    View in: PubMed
    Score: 0.036
  126. Association of adiposity genetic variants with menarche timing in 92,105 women of European descent. Am J Epidemiol. 2013 Aug 01; 178(3):451-60.
    View in: PubMed
    Score: 0.036
  127. A genome-wide association study of early menopause and the combined impact of identified variants. Hum Mol Genet. 2013 Apr 01; 22(7):1465-72.
    View in: PubMed
    Score: 0.035
  128. Lipoprotein(a), polymorphisms in the LPA gene, and incident venous thromboembolism among 21483 women. J Thromb Haemost. 2013 Jan; 11(1):205-8.
    View in: PubMed
    Score: 0.035
  129. Genome-wide linkage and association analyses implicate FASN in predisposition to Uterine Leiomyomata. Am J Hum Genet. 2012 Oct 05; 91(4):621-8.
    View in: PubMed
    Score: 0.035
  130. Biomarkers and functional outcomes from ischaemic cerebral events in women: a prospective cohort study. Eur J Neurol. 2013 Feb; 20(2):375-81.
    View in: PubMed
    Score: 0.035
  131. A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. Hum Mol Genet. 2012 Dec 15; 21(24):5373-84.
    View in: PubMed
    Score: 0.034
  132. An X chromosome association scan of the Norfolk Island genetic isolate provides evidence for a novel migraine susceptibility locus at Xq12. PLoS One. 2012; 7(5):e37903.
    View in: PubMed
    Score: 0.034
  133. Cardiovascular inflammation in healthy women: multilevel associations with state-level prosperity, productivity and income inequality. BMC Public Health. 2012 Mar 20; 12:211.
    View in: PubMed
    Score: 0.033
  134. Reproductive aging-associated common genetic variants and the risk of breast cancer. Breast Cancer Res. 2012 Mar 20; 14(2):R54.
    View in: PubMed
    Score: 0.033
  135. Comparison of associations of adherence to a Dietary Approaches to Stop Hypertension (DASH)-style diet with risks of cardiovascular disease and venous thromboembolism. J Thromb Haemost. 2012 Feb; 10(2):189-98.
    View in: PubMed
    Score: 0.033
  136. Meta-analyses identify 13 loci associated with age at menopause and highlight DNA repair and immune pathways. Nat Genet. 2012 Jan 22; 44(3):260-8.
    View in: PubMed
    Score: 0.033
  137. Socioeconomic status and incident type 2 diabetes mellitus: data from the Women's Health Study. PLoS One. 2011; 6(12):e27670.
    View in: PubMed
    Score: 0.033
  138. Association of high-density lipoprotein cholesterol with incident cardiovascular events in women, by low-density lipoprotein cholesterol and apolipoprotein B100 levels: a cohort study. Ann Intern Med. 2011 Dec 06; 155(11):742-50.
    View in: PubMed
    Score: 0.033
  139. The effect of chronic platelet inhibition with low-dose aspirin on atherosclerotic progression and acute thrombosis: clinical evidence from the Physicians' Health Study. Am Heart J. 1991 Dec; 122(6):1588-92.
    View in: PubMed
    Score: 0.033
  140. Aspirin for primary prevention of vascular events in women: individualized prediction of treatment effects. Eur Heart J. 2011 Dec; 32(23):2962-9.
    View in: PubMed
    Score: 0.033
  141. Clinical characteristics of nonfatal myocardial infarction among individuals on prophylactic low-dose aspirin therapy. Circulation. 1991 Aug; 84(2):708-11.
    View in: PubMed
    Score: 0.032
  142. Genetic determinants of cardiovascular events among women with migraine: a genome-wide association study. PLoS One. 2011; 6(7):e22106.
    View in: PubMed
    Score: 0.032
  143. The relative importance of systolic versus diastolic blood pressure control and incident symptomatic peripheral artery disease in women. Vasc Med. 2011 Aug; 16(4):239-46.
    View in: PubMed
    Score: 0.032
  144. Genome-wide association study reveals three susceptibility loci for common migraine in the general population. Nat Genet. 2011 Jun 12; 43(7):695-8.
    View in: PubMed
    Score: 0.032
  145. Smoking, smoking cessation, [corrected] and risk for symptomatic peripheral artery disease in women: a cohort study. Ann Intern Med. 2011 Jun 07; 154(11):719-26.
    View in: PubMed
    Score: 0.032
  146. Low-dose aspirin therapy for chronic stable angina. A randomized, placebo-controlled clinical trial. Ann Intern Med. 1991 May 15; 114(10):835-9.
    View in: PubMed
    Score: 0.031
  147. Meta-analysis of genome-wide association studies in >80 000 subjects identifies multiple loci for C-reactive protein levels. Circulation. 2011 Feb 22; 123(7):731-8.
    View in: PubMed
    Score: 0.031
  148. Physical activity modifies the effect of LPL, LIPC, and CETP polymorphisms on HDL-C levels and the risk of myocardial infarction in women of European ancestry. Circ Cardiovasc Genet. 2011 Feb; 4(1):74-80.
    View in: PubMed
    Score: 0.031
  149. Oral postmenopausal hormone therapy, C-reactive protein, and cardiovascular outcomes. Menopause. 2011 Jan; 18(1):23-9.
    View in: PubMed
    Score: 0.031
  150. Hemoglobin A1c, body mass index, and the risk of hypertension in women. Am J Hypertens. 2011 Mar; 24(3):328-34.
    View in: PubMed
    Score: 0.031
  151. Thirty new loci for age at menarche identified by a meta-analysis of genome-wide association studies. Nat Genet. 2010 Dec; 42(12):1077-85.
    View in: PubMed
    Score: 0.030
  152. The fat-mass and obesity-associated (FTO) gene, physical activity, and risk of incident cardiovascular events in white women. Am Heart J. 2010 Dec; 160(6):1163-9.
    View in: PubMed
    Score: 0.030
  153. Circadian variation of acute myocardial infarction and the effect of low-dose aspirin in a randomized trial of physicians. Circulation. 1990 Sep; 82(3):897-902.
    View in: PubMed
    Score: 0.030
  154. A large-scale candidate gene association study of age at menarche and age at natural menopause. Hum Genet. 2010 Nov; 128(5):515-27.
    View in: PubMed
    Score: 0.030
  155. The long- and short-term impact of elevated body mass index on the risk of new atrial fibrillation the WHS (women's health study). J Am Coll Cardiol. 2010 May 25; 55(21):2319-27.
    View in: PubMed
    Score: 0.029
  156. A multimarker approach to assess the influence of inflammation on the incidence of atrial fibrillation in women. Eur Heart J. 2010 Jul; 31(14):1730-6.
    View in: PubMed
    Score: 0.029
  157. Association of genetic variants with the metabolic syndrome in 20,806 white women: The Women's Health Genome Study. Am Heart J. 2009 Aug; 158(2):257-262.e1.
    View in: PubMed
    Score: 0.028
  158. Genome-wide association studies identify loci associated with age at menarche and age at natural menopause. Nat Genet. 2009 Jun; 41(6):724-8.
    View in: PubMed
    Score: 0.027
  159. Candidate genetic variants in the fibrinogen, methylenetetrahydrofolate reductase, and intercellular adhesion molecule-1 genes and plasma levels of fibrinogen, homocysteine, and intercellular adhesion molecule-1 among various race/ethnic groups: data from the Women's Genome Health Study. Am Heart J. 2009 Apr; 157(4):777-83.e1.
    View in: PubMed
    Score: 0.027
  160. Socioeconomic status, blood pressure progression, and incident hypertension in a prospective cohort of female health professionals. Eur Heart J. 2009 Jun; 30(11):1378-84.
    View in: PubMed
    Score: 0.027
  161. Association of 77 polymorphisms in 52 candidate genes with blood pressure progression and incident hypertension: the Women's Genome Health Study. J Hypertens. 2009 Mar; 27(3):476-83.
    View in: PubMed
    Score: 0.027
  162. Association between polymorphisms in the beta2-adrenergic receptor gene with myocardial infarction and ischaemic stroke in women. Thromb Haemost. 2009 Feb; 101(2):351-8.
    View in: PubMed
    Score: 0.027
  163. Association of renin-angiotensin and endothelial nitric oxide synthase gene polymorphisms with blood pressure progression and incident hypertension: prospective cohort study. J Hypertens. 2008 Sep; 26(9):1780-6.
    View in: PubMed
    Score: 0.026
  164. Association between polymorphisms in the beta2-adrenoceptor gene and migraine in women. Headache. 2009 Feb; 49(2):235-44.
    View in: PubMed
    Score: 0.026
  165. Genetic variation of the androgen receptor and risk of myocardial infarction and ischemic stroke in women. Stroke. 2008 May; 39(5):1590-2.
    View in: PubMed
    Score: 0.025
  166. Dietary glycemic index, dietary glycemic load, blood lipids, and C-reactive protein. Metabolism. 2008 Mar; 57(3):437-43.
    View in: PubMed
    Score: 0.025
  167. Renin-angiotensin and endothelial nitric oxide synthase gene polymorphisms are not associated with the risk of incident type 2 diabetes mellitus: a prospective cohort study. J Intern Med. 2008 Apr; 263(4):376-85.
    View in: PubMed
    Score: 0.025
  168. Comparison of usefulness of body mass index versus metabolic risk factors in predicting 10-year risk of cardiovascular events in women. Am J Cardiol. 2007 Dec 01; 100(11):1654-8.
    View in: PubMed
    Score: 0.025
  169. HbA1c measured in stored erythrocytes and mortality rate among middle-aged and older women. Diabetologia. 2008 Feb; 51(2):267-75.
    View in: PubMed
    Score: 0.025
  170. Natriuretic peptide precursor a gene polymorphisms and risk of blood pressure progression and incident hypertension. Hypertension. 2007 Dec; 50(6):1114-9.
    View in: PubMed
    Score: 0.025
  171. Physical activity and reduced risk of cardiovascular events: potential mediating mechanisms. Circulation. 2007 Nov 06; 116(19):2110-8.
    View in: PubMed
    Score: 0.025
  172. Blood pressure and risk of developing type 2 diabetes mellitus: the Women's Health Study. Eur Heart J. 2007 Dec; 28(23):2937-43.
    View in: PubMed
    Score: 0.025
  173. The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol. 2007; 22(12):839-69.
    View in: PubMed
    Score: 0.024
  174. Risk of cardiovascular events among women with high normal blood pressure or blood pressure progression: prospective cohort study. BMJ. 2007 Sep 01; 335(7617):432.
    View in: PubMed
    Score: 0.024
  175. Polymorphisms and haplotypes of the estrogen receptor-beta gene (ESR2) and cardiovascular disease in men and women. Clin Chem. 2007 Oct; 53(10):1749-56.
    View in: PubMed
    Score: 0.024
  176. Awareness, accuracy, and predictive validity of self-reported cholesterol in women. J Gen Intern Med. 2007 May; 22(5):606-13.
    View in: PubMed
    Score: 0.024
  177. Lipid levels and the risk of ischemic stroke in women. Neurology. 2007 Feb 20; 68(8):556-62.
    View in: PubMed
    Score: 0.023
  178. Comparison of interleukin-6 and C-reactive protein for the risk of developing hypertension in women. Hypertension. 2007 Feb; 49(2):304-10.
    View in: PubMed
    Score: 0.023
  179. C-reactive protein in the prediction of rheumatoid arthritis in women. Arch Intern Med. 2006 Dec 11-25; 166(22):2490-4.
    View in: PubMed
    Score: 0.023
  180. Low sex hormone-binding globulin is associated with the metabolic syndrome in postmenopausal women. Metabolism. 2006 Nov; 55(11):1473-80.
    View in: PubMed
    Score: 0.023
  181. High-sensitivity C-reactive protein and cognitive function in older women. Epidemiology. 2006 Mar; 17(2):183-9.
    View in: PubMed
    Score: 0.022
  182. A prospective study of hemoglobin A1c concentrations and risk of breast cancer in women. Cancer Res. 2006 Mar 01; 66(5):2869-75.
    View in: PubMed
    Score: 0.022
  183. Hemoglobin A1c concentrations and risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev. 2005 Dec; 14(12):3010-2.
    View in: PubMed
    Score: 0.022
  184. A prospective study of plasma lipid levels and hypertension in women. Arch Intern Med. 2005 Nov 14; 165(20):2420-7.
    View in: PubMed
    Score: 0.021
  185. Sex hormone-binding globulin and serum testosterone are inversely associated with C-reactive protein levels in postmenopausal women at high risk for cardiovascular disease. Ann Epidemiol. 2006 Feb; 16(2):105-12.
    View in: PubMed
    Score: 0.021
  186. Association between consumption of beer, wine, and liquor and plasma concentration of high-sensitivity C-reactive protein in women aged 39 to 89 years. Am J Cardiol. 2005 Jul 01; 96(1):83-8.
    View in: PubMed
    Score: 0.021
  187. Magnesium intake, C-reactive protein, and the prevalence of metabolic syndrome in middle-aged and older U.S. women. Diabetes Care. 2005 Jun; 28(6):1438-44.
    View in: PubMed
    Score: 0.021
  188. Hemoglobin A1c level and future cardiovascular events among women. Arch Intern Med. 2004 Apr 12; 164(7):757-61.
    View in: PubMed
    Score: 0.019
  189. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med. 1996 May 02; 334(18):1145-9.
    View in: PubMed
    Score: 0.011
  190. A secondary prevention trial of antioxidant vitamins and cardiovascular disease in women. Rationale, design, and methods. The WACS Research Group. Ann Epidemiol. 1995 Jul; 5(4):261-9.
    View in: PubMed
    Score: 0.010
  191. Height and incidence of cardiovascular disease in male physicians. Circulation. 1993 Oct; 88(4 Pt 1):1437-43.
    View in: PubMed
    Score: 0.009
  192. The primary prevention of myocardial infarction. N Engl J Med. 1992 May 21; 326(21):1406-16.
    View in: PubMed
    Score: 0.008
  193. Aspirin in the primary prevention of angina pectoris in a randomized trial of United States physicians. Am J Med. 1990 Dec; 89(6):772-6.
    View in: PubMed
    Score: 0.008
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.